Aratana Therapeutics (PETX) trades higher in its debut, currently over $8 after pricing its 5,750,000 share IPO at $6 per share and opening this morning at $7. The company is a development-stage biopharmaceutical company focused on prescription medications for pets. Stifel and Lazard Capital Markets are co-leads for the offering.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs